Omeros Announces Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Omeros (OMER) Prices 3M Common Stock Offering at $22.75/Share
August 15, 2017 9:18 AM EDTOmeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, complement-mediated diseases and disorders of the central nervous system, announced today the pricing of its previously announced underwritten public offering of 3,000,000 shares of its common stock at a price to the public of $22.75 per share, before deducting underwriting discounts and other estimated offering expenses. This bought deal offering is expected to close on or about August 18, 2017, subject to the satisfaction of... More



